RL

Russ Lebovitz

CEO at Amprion Inc.

San Francisco, California

Invests in

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

  • CEO

    2007

    Amprion focuses on highly sensitive, early detection of misfolded prion proteins responsible for progressive neurodegeneration in Alzheimer's, Parkinson's and other CNS degenerative diseases. Amprion's mission is to end Alzheimer's and Parkinson's through early molecular detection plus accelerated development of effective treatments.

  • Director

    2013

    Leading a focused team of multi-talented & highly experienced cosmetic, scientific and medical professionals through development, marketing and sales of highly novel, proprietary products to dramatically improve the appearance of age and sun-damaged skin.

  • Global Venture Partner

    2016

    BootstrapLabs is a leading Venture Capital firm based in Silicon Valley and focused on Applied Artificial Intelligence

  • Managing Partner

    1996

    Suma Ventures identifies emerging growth areas in the life sciences and cleantech industries and partners with leading universities and entrepreneurs to create and grow substantive companies in these areas.

2017 - 2022

  • Director

    2017 - 2022

    Ambra BioScience is focused on improving our understanding of the complex relationship between nutrition, digestion and health.

2006 - 2012

  • President & CEO

    2006 - 2012

    Marval is developing next-generation contrast agents with enhanced efficacy, function and safety for CT and XRay applications.

2006 - 2008

  • President/CEO

    2006 - 2008

    Early-stage MRI contrast-agent development company.

2003 - 2006

  • President/CEO

    2003 - 2006

    Managed fundraising, M&A activiities and joint venture relationships with large pharma partners.